AALL0434: Intensified Methotrexate, Nelarabine (Compound 506U78; IND#52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) or T-cell Lymphoblastic Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date10/3/19 → 8/31/50

Funding

  • Children’s Hospital of Philadelphia
  • Novartis Pharmaceuticals Corporation